QUADRANT CAPITAL GROUP LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 3 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 2.3%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,381
+371.1%
3,590
+638.7%
0.00%
Q2 2023$2,416
-11.7%
486
-12.3%
0.00%
Q1 2023$2,737
+1111.1%
554
+1438.9%
0.00%
Q4 2022$226
-97.5%
36
-95.6%
0.00%
-100.0%
Q3 2022$9,0000.0%8260.0%0.00%0.0%
Q2 2022$9,000
-30.8%
826
-41.5%
0.00%
-50.0%
Q1 2022$13,000
+160.0%
1,413
+294.7%
0.00%
+100.0%
Q4 2021$5,000
+150.0%
358
+316.3%
0.00%
Q3 2021$2,00086
+975.0%
0.00%
Q2 2021$080.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$26,829,00010.04%
Wildcat Capital Management, LLC 1,716,370$25,608,0004.17%
TPG GP A, LLC 18,716,306$279,247,0002.79%
Casdin Capital, LLC 2,650,000$39,538,0001.11%
Lombard Odier Asset Management (Switzerland) SA 996,116$14,862,0000.95%
Coastal Bridge Advisors, LLC 301,929$4,505,0000.94%
HARBOR CAPITAL ADVISORS, INC. 119,547$1,784,0000.65%
Pier Capital, LLC 294,968$4,401,0000.46%
Navalign, LLC 64,428$961,0000.38%
Gratus Capital, LLC 191,871$2,863,0000.26%
View complete list of ALLOGENE THERAPEUTICS INC shareholders